期刊文献+

壮族成年人不同性别年龄与血脂水平变化的关系 被引量:3

The study on the relationship between the sex&age and the change of blood lipid levels in Zhuang nationality adults
下载PDF
导出
摘要 目的探讨壮族成年城镇居民性别、年龄与血脂水平变化的关系。方法检测1725例壮族成年城镇居民的血清血脂五项。结果CHO 5.48±1.11 mmol/L,HDL-C 1.26±0.28 mmol/L,LDL-C 3.55±1.02 mmol/L,VLDL-C 0.67±0.40 mmol/L,TG 1.48±0.89 mmol/L,不同性别血脂水平差异有显著性(P<0.01),不同年龄段的血脂水平差异也有显著性(P<0.01)。血脂水平在70岁以后出现波动大的现象。结论壮族成年人血脂水平不仅与性别有关,而且与年龄的变化也有关,老年人血脂水平出现很大波动的现象。 Objective To study the relationship between the sex and age and the change of blood lipid levels in Zhuang nationality adults in towns. Methods The levels of blood lipi'ds from 1725 Zhuang nationality adults in towns were tested. Results CHO 5. 48±11.11 mmol/L. HDL-C 1. 26±0.28mmol/L. LDL-C 3.55±1.02mmol/L. VLDL- C 0.67±0.4 mmol/L. TG 1.48±0.89mmol/L. There were statistically significant difference in CHO,HDL-C,LDL- C and VLDL-C between male and female( P 〈0.01) ,and a significant differences among ages( P 〈0.01). There were great variations in the levels of blood lipids after seventy years old. Conclusion Levels of blood lipids are not only related to the sex, but also related to the change of age. There is a great variation in the levels of blood lipids among old people.
出处 《右江医学》 2006年第4期345-347,共3页 Chinese Youjiang Medical Journal
基金 2001年广西科学研究与技术开发计划项目(桂科技字[2001]41号)
关键词 壮族人 胆固醇 血脂水平 zhuang nationality cholesterol blood lipid level
  • 相关文献

参考文献6

  • 1陆克兴,李天资,潘兴寿,黄照河,蓝景生,袁锡华.壮族城镇居民血脂分布特征研究[J].右江医学,2006,34(2):123-125. 被引量:6
  • 2Ginsberg HN.Increase in dietary cholesterol and associated with modest increases in both LDL and HDL cholesterol in healthy young women[J].Arterioscler Thromb Vasc Biol,1995,15:169.
  • 3Robins SJ,Collins D,Wittes JT,et al.Relation of gemfibrozil treatment and lipid levels with major coronary events.VA-HIT:a randomized controlled trial[J].JAMA,2001,285:1585-1591.
  • 4Blasetto J,Stein E,Brown WV,et al.Efficacy of rosuvastatin compared with other statins at selected starting doses in hypercholesterolemic patients and in special population groups[J].Am J Cardiol,2003,91 (suppl 5A):3C-10.
  • 5Gagne C,Bays HE,Weiss SR,et al.Efficary and safety of ezetimibe added to ongoing statin therapy for treatment of patients with primary hypercholesterolemia[J].Am J Cardio,2002,90:1084-1091.
  • 6Eric Bruckert.New advances in Lipid-Modifying therapies for reducing cardiovascular risk[J].Cardiolong,2002,97:59-66.

二级参考文献5

  • 1Robins SJ,Collins D,Wittes JT,et al.Relation of gemfibrozil treatment and lipid levels with major coronary events[J].VA-HIT:a randomized controlled trial.JAMA,2001,285:1585-1591.
  • 2Serruys PWJC,de Feyter P,Macaya C,et al.Fluvastatin for prevention of cardiac events following successful first percutaneous coronary intervention[J].JAMA,2002,287:3215-3222.
  • 3Blasetto J,Stein E,Brown WV,et al.Efficacy of rosuvastatin compared with other statins at selected starting doses in hypercholesterolemic patients and in special population groups[J].Am J Cardiol,2003,91 (suppl 5A):3C-10.
  • 4Gagne C,Bays HE,Weiss SR,et al.Efficary and safety of ezetimibe added to ongoing statin therapy for treatment of patients with primary hypercholesterolemia[J].Am J Cardio,2002,90:1084-1091.
  • 5Lattin JM,Carroll JD,Green PE.Analyzing Multivariate Data[J].Brooks Cole,2003.50:111-132.SPSS Base 12 User's Guide.SPSS Inc[J].Chicago,Illinois,2003,391-399.

共引文献5

同被引文献37

引证文献3

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部